Comparative Benchmarking
In the context of the broader market, PHVS competes directly with industry leaders such as ZYME and AMLX. With a market capitalization of $1.76B, it holds a leading position in the sector. When comparing efficiency, PHVS's gross margin of N/A stands against ZYME's 100.00% and AMLX's N/A. Such benchmarking helps identify whether Pharvaris NV is trading at a premium or discount relative to its financial performance.
